YahooSeptember 30, 2026 at 11:00 AM NY27 Days Ago
CADL Slips Despite Encouraging Prostate Cancer Drug Data — Retail Believes Stock Is ‘Clearly A Buy And Hold’
Candel’s experimental therapy combined with radiation therapy improved outcomes in patients with localized prostate cancer
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
